References & Further Reading
The information presented on this platform is based on current clinical guidelines, government reports from the Federal Republic of Germany, and peer-reviewed international scientific literature. Below you will find the primary sources used to define our scope of therapy.
I. German Clinical Guidelines & Regulatory Data
These documents form the legal and medical basis for prescribing cannabis in Germany.
1. German Society for Pain Medicine (DGS)
Title: Clinical Practice Guideline: Cannabis-Based Medications in Pain Management (Version 2.0)
Published: August 2024
Relevance: This is the primary guideline for German physicians. It defines the standard of care for the use of cannabinoids in the treatment of chronic pain, spasticity, and palliative symptoms.
2. Federal Institute for Drugs and Medical Devices (BfArM)
Title: Final Report on the Accompanying Survey Pursuant to Section 31(6) of Book V of the Social Code (SGB V) on the Prescription and Use of Cannabis Medicines
Published: July 2022
Relevance: The official final report of the German government’s 5-year study. It analyzes data from over 16,000 patients, providing the most accurate statistics on which conditions are treated (e.g., pain, MS, ADHD) and the safety profile of the therapy in Germany.
II. Pharmacology & Mechanism of Action
Scientific reviews detailing the endocannabinoid system (ECS) and phytocannabinoids.
3. Health Canada
Title: Information for Health Care Professionals: Cannabis and Cannabinoids
Published: October 2018
Relevance: One of the world’s most comprehensive government-sponsored reviews of cannabis research. It is cited here to highlight the broad range of conditions studied (including hypertension, glaucoma, and inflammatory diseases) and pharmacological interactions.
4. National Academies of Sciences, Engineering, and Medicine (NASEM)
Title: The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research
Published: 2017
Relevance: A landmark U.S. review assessing the strength of evidence for various therapeutic uses (conclusive, substantial, moderate, or limited evidence).
5. Pertwee RG (Ed.), Oxford University Press
Title: Handbook of Cannabis
Published: 2014
Relevance: Edited by a leading European pharmacologist, this definitive text presents the established consensus on the mechanisms and physiology of endocannabinoid receptors.
III. Historical Context
Academic sources documenting the ethnobotanical history of the plant.
5. Russo, E. B.
Title: History of Cannabis and Its Preparations in Saga, Science, and Sobriquet
Journal: Chemistry & Biodiversity (Vol. 4, Issue 8)
Published: August 2007
Relevance: The definitive academic timeline of cannabis, covering its use from the Neolithic period and Ancient China/India to its introduction in Western medicine by W.B. O'Shaughnessy in the 19th century.
6. Zuardi, A. W.
Title: History of cannabis as a medicine: a review
Journal: Revista Brasileira de Psiquiatria (Vol. 28, Issue 2)
Published: June 2006
Relevance: A focused medical review detailing the transition of cannabis from traditional folk medicine to a regulated pharmaceutical substance in the 20th century.
IV. Organ-Specific Systemic Effects
Selected peer-reviewed literature detailing the regulatory role of the endocannabinoid system (ECS) across major body systems.
7. Immune System
Organ/System: Immune System
Source: Cellular and Molecular Life Sciences
Paper: "The CB2 receptor and its role as a regulator of inflammation"
Publication Date: 2016
Citation: Turcotte C, Blanchet M-R, Laviolette M, Flamand N.
8. Nervous System
Organ: Brain
Source: International Journal of Molecular Sciences
Paper: "Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System"
Publication Date: 2018
Citation: Vol. 19, Issue 3 (Zou S, Kumar U.)
9. Respiratory System
Organ: Lungs
Source: Molecules
Paper: "The Endocannabinoid System in the Airways"
Publication Date: 2019
Citation: Vol. 24, No. 24 (Bozkurt TE.)
10. Reproductive System
Organ: Reproductive Organs
Source: Human Reproduction Update
Paper: "Endocannabinoids and Reproduction"
Publication Date: 2007
Citation: Taylor AH et al.
11. Digestive System
Organ: Colon
Source: Current Opinion in Pharmacology
Paper: "The Endocannabinoid System and Gastrointestinal Disease"
Publication Date: 2006
Citation: Di Marzo V, Izzo AA.
Organ: Pancreas
Source: Diabetologia
Paper: "Presence of functional cannabinoid receptors in the human endocrine pancreas"
Publication Date: 2008
Citation: Bermúdez-Silva FJ et al.
Organ: Liver
Source: Journal of Hepatology
Paper: "Cannabinoid Signaling and Liver Therapeutics"
Publication Date: 2013
Citation: Vol. 59, No. 4, pp. 891–896
12. Immune & Lymphatic System
Organ: Spleen & Immune Cells
Source: Cellular and Molecular Life Sciences
Paper: "The CB2 receptor and its role as a regulator of inflammation"
Publication Date: 2016
Citation: Turcotte C, Blanchet M-R, Laviolette M, Flamand N.
13. Integumentary System
Organ: Skin
Source: Trends in Pharmacological Sciences
Paper: "The Endocannabinoid System of the Skin in Health and Disease: Novel Perspectives and Therapeutic Opportunities"
Publication Date: 2009
Citation: Bíró T et al.
14. Musculoskeletal System
Organ: Muscles (Skeletal)
Source: Obesity Reviews
Paper: "The Role of the Endocannabinoid System in Skeletal Muscle and Metabolic Adaptations to Exercise: Potential Implications for the Treatment of Obesity"
Publication Date: 2012
Citation: Heyman E et al.
Organ: Bones
Source: Journal of Neuroendocrinology
Paper: "Endocannabinoids and the Regulation of Bone Metabolism"
Publication Date: 2008
Citation: Bab I, Ofek O, Tam J, et al.